14
Views
4
CrossRef citations to date
0
Altmetric
Original

Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML

, , , , , , , , , , & , PhD show all
Pages 290-298 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ming Ni, Jean-Marc Hoffmann, Michael Schmitt & Anita Schmitt. (2016) Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies. Expert Opinion on Biological Therapy 16:9, pages 1113-1123.
Read now
Anne Flörcken, Joachim Kopp, Uwe Kölsch, Christian Meisel, Bernd Dörken, Antonio Pezzutto & Jörg Westermann. (2016) DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties. Human Vaccines & Immunotherapeutics 12:5, pages 1117-1123.
Read now
Athalia R Pyzer, David E Avigan & Jacalyn Rosenblatt. (2014) Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies. Human Vaccines & Immunotherapeutics 10:11, pages 3125-3131.
Read now
Owen Proudfoot, Dodie Pouniotis, Kuo-Ching Sheng, Bruce E Loveland & Geoffrey A Pietersz. (2007) Dendritic cell vaccination. Expert Review of Vaccines 6:4, pages 617-633.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.